Contract 80JSC023FA162
Sti Legacy, Inc. · National Aeronautics And Space Administration · July 9, 2024
Sti Legacy, Inc. was awarded a federal contract by National Aeronautics And Space Administration on July 9, 2024 for $1.76 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Lexington, KY. This is a task or delivery order issued under parent IDIQ 80JSC023DA015. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $1.76 million.
Contract details
- PIID
- 80JSC023FA162
- Parent IDIQ
- 80JSC023DA015
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Space R&D Services; Space Flight, Research And Supporting Activities; Experimental Development
- Place of performance
- Lexington, KY
- First action
- July 9, 2024
Description
FOUR FULL SERVICE PAYLOAD INTERGRATION USES
Modification timeline
-
July 9, 2024Mod P00002 · Supplemental Agreement For Work Within Scope$1.76M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Melanie Sauer & Associates Llc | National Aeronautics And Space Administration | March 23, 2026 | $110.0K |
| Sti Legacy, Inc. | National Aeronautics And Space Administration | March 11, 2026 | $0 |
| National Stem Cell Foundation Inc. | National Aeronautics And Space Administration | February 17, 2026 | $1.68M |
| Redwire Space Technologies, Inc. | National Aeronautics And Space Administration | February 13, 2026 | $415.6K |
| Redwire Space Technologies, Inc. | National Aeronautics And Space Administration | February 5, 2026 | $3.23M |
| Aspera Biomedicines, Inc. | National Aeronautics And Space Administration | January 30, 2026 | $3.24M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 80JSC023FA162?
Contract 80JSC023FA162 is a federal contract awarded to Sti Legacy, Inc. by National Aeronautics And Space Administration on July 9, 2024 for $1.76 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 80JSC023FA162?
Sti Legacy, Inc. won contract 80JSC023FA162 from National Aeronautics And Space Administration.
How much is contract 80JSC023FA162 worth?
Contract 80JSC023FA162 has obligated $0 to date but carries a potential ceiling of $1.76 million if fully funded and all options are exercised.